Fast Five Quiz: How Much Do You Know About 'Broken-Heart Syndrome'?

Yasmine S. Ali, MD, MSCI

Disclosures

January 22, 2018

Cardiac markers, specifically troponin I and troponin T, are elevated in 90% of patients with Takotsubo cardiomyopathy, although to a lesser magnitude than is seen in STEMI. The BNP level is also frequently elevated.

Investigators found evidence that the following ratios were capable of distinguishing Takotsubo cardiomyopathy from STEMI at an early stage:

  • Ratio of NTproBNP to troponin I

  • Ratio of NTproBNP to creatine kinase MB (CKMB) mass

  • Ratio of NTproBNP to EF

Of these, the most accurate marker was the NTproBNP-to-troponin-I ratio.

Several studies looked at levels of circulating catecholamines in the acute phase and found that nearly 75% of patients had elevations markedly higher than those of patients with STEMI.

For more on the workup for Takotsubo cardiomyopathy, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....